CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Krystal Biotech, Inc. - KRYS CFD

    120.40
    2.63%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.21
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Krystal Biotech Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 117.32
    开仓* 116.29
    1 年变化* 110.59%
    日范围* 116.29 - 120.4
    52 周范围 49.17-123.84
    平均交易量（10 天） 566.20K
    平均交易量（3 个月) 5.76M
    市值 3.32B
    市盈率 -100.00K
    流通股 27.53M
    收入 N/A
    EPS -5.28
    股息（收益率 %） N/A
    贝塔 0.85
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    May 26, 2023 120.40 3.23 2.76% 117.17 120.58 116.25
    May 25, 2023 117.32 2.45 2.13% 114.87 120.33 114.87
    May 24, 2023 118.43 3.55 3.09% 114.88 120.02 113.43
    May 23, 2023 118.91 1.99 1.70% 116.92 123.52 116.81
    May 22, 2023 117.45 17.52 17.53% 99.93 119.58 99.93
    May 19, 2023 95.93 8.53 9.76% 87.40 97.04 86.98
    May 18, 2023 87.33 0.79 0.91% 86.54 87.84 85.94
    May 17, 2023 88.02 -1.02 -1.15% 89.04 89.04 86.39
    May 16, 2023 88.40 0.91 1.04% 87.49 89.33 86.49
    May 15, 2023 89.91 1.73 1.96% 88.18 92.33 86.94
    May 12, 2023 88.00 -2.34 -2.59% 90.34 90.78 87.47
    May 11, 2023 90.25 0.23 0.26% 90.02 91.06 87.53
    May 10, 2023 89.99 -1.94 -2.11% 91.93 92.93 89.94
    May 9, 2023 91.74 5.15 5.95% 86.59 92.09 85.98
    May 8, 2023 87.55 3.19 3.78% 84.36 87.58 83.04
    May 5, 2023 84.07 2.13 2.60% 81.94 84.21 81.77
    May 4, 2023 82.03 -0.91 -1.10% 82.94 83.41 82.02
    May 3, 2023 83.85 1.40 1.70% 82.45 85.76 82.26
    May 2, 2023 82.75 -3.34 -3.88% 86.09 86.50 82.45
    May 1, 2023 85.93 2.15 2.57% 83.78 86.12 83.37

    Krystal Biotech, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 Krystal Biotech Inc Earnings Release
    Q2 2023 Krystal Biotech Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Q3 2023 Krystal Biotech Inc Earnings Release
    Q3 2023 Krystal Biotech Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    收入
    总营业费用 145.196 68.275 32.999 22.081 11.916
    销售/一般/行政费用，总计 77.735 40.391 15.063 6.465 4.155
    研究与开发 42.461 27.884 17.936 15.616 7.761
    营业收入 -145.196 -68.275 -32.999 -22.081 -11.916
    利息收入（费用），非经营净值 5.221 -1.295 0.832 2.993 1.027
    税前净收入 -139.975 -69.57 -32.167 -19.088 -10.889
    税后净收入 -139.975 -69.57 -32.167 -19.088 -10.889
    未计算非常项目前的净收益 -139.975 -69.57 -32.167 -19.088 -10.889
    净收入 -139.975 -69.57 -32.167 -19.088 -10.889
    普通股股东可获收益 (不含非经常性项目) -139.975 -69.57 -32.167 -19.088 -10.889
    普通股股东可获收益 (含非經常性項目) -139.975 -69.57 -32.167 -19.088 -10.889
    摊薄调整
    摊薄净收入 -139.975 -69.57 -32.167 -19.088 -10.889
    摊薄后加权平均股 25.4917 22.1968 18.7872 15.9011 11.2031
    扣除特别项目的每股摊薄盈利 -5.491 -3.13423 -1.71218 -1.20042 -0.97196
    Dividends per Share - Common Stock Primary Issue
    每股正常摊薄盈利 -4.51029 -3.13423 -1.71218 -1.20042 -0.97196
    非常规项目总计 0
    Total Adjustments to Net Income 0
    异常费用（收入） 25
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    总营业费用 48.823 34.771 31.451 28.753 50.222
    销售/一般/行政费用，总计 24.035 24.03 19.935 17.863 15.908
    研究与开发 12.288 10.741 11.516 10.89 9.314
    营业收入 -48.823 -34.771 -31.451 -28.753 -50.222
    利息收入（费用），非经营净值 3.526 2.719 1.601 0.645 0.257
    税前净收入 -45.297 -32.052 -29.85 -28.108 -49.965
    税后净收入 -45.297 -32.052 -29.85 -28.108 -49.965
    未计算非常项目前的净收益 -45.297 -32.052 -29.85 -28.108 -49.965
    净收入 -45.297 -32.052 -29.85 -28.108 -49.965
    普通股股东可获收益 (不含非经常性项目) -45.297 -32.052 -29.85 -28.108 -49.965
    普通股股东可获收益 (含非經常性項目) -45.297 -32.052 -29.85 -28.108 -49.965
    摊薄净收入 -45.297 -32.052 -29.85 -28.108 -49.965
    摊薄后加权平均股 25.7122 25.6826 25.6191 25.5452 25.1145
    扣除特别项目的每股摊薄盈利 -1.76169 -1.248 -1.16515 -1.10033 -1.98949
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -1.27554 -1.248 -1.16515 -1.10033 -0.99405
    异常费用（收入） 12.5 0 0 0 25
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 383.779 442.267 275.058 195.88 112.65
    现金和短期投资 379.171 438.096 271.262 193.685 111.761
    现金等价物 161.9 341.246 268.269 187.514 103.67
    Prepaid Expenses 4.608 4.171 3.796 2.195 0.889
    Other Current Assets, Total
    Total Assets 558.45 626.295 310.844 209.023 116.116
    Property/Plant/Equipment, Total - Net 169.726 119.583 34.174 11.184 3.014
    Property/Plant/Equipment, Total - Gross 176.519 123.797 36.542 12.034 3.18
    Accumulated Depreciation, Total -6.793 -4.214 -2.368 -0.85 -0.166
    Total Current Liabilities 28.847 25.736 15.452 3.327 2.596
    Accounts Payable 3.981 8.398 2.105 0.724 0.888
    Accrued Expenses 24.556 17.168 5.681 2.544 1.515
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Total Liabilities 36.219 32.719 18.76 6.109 2.89
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 7.372 6.983 3.308 2.782 0.294
    Total Equity 522.231 593.576 292.084 202.914 113.226
    Redeemable Preferred Stock 0 0
    Common Stock 0.00026 0.003 0.0002 0.00017 0
    Additional Paid-In Capital 803.718 734.523 363.292 241.951 133.183
    Retained Earnings (Accumulated Deficit) -280.759 -140.787 -71.214 -39.047 -19.959
    Total Liabilities & Shareholders’ Equity 558.45 626.295 310.844 209.023 116.116
    Total Common Shares Outstanding 25.7637 25.208 19.7142 17.3543 14.4289
    Other Current Liabilities, Total 0.31 0.17 7.666 0.059 0.193
    短期投资 217.271 96.85 2.993 6.171 8.091
    Other Long Term Assets, Total 0.324 0.074 1.612 1.462 0.452
    Other Equity, Total -0.72826 -0.163 0.0058 0.00983 0.002
    Long Term Investments 4.621 64.371 0 0.497
    Preferred Stock - Non Redeemable, Net 0 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 355.429 383.779 397.578 428.77 437.998
    现金和短期投资 350.387 379.171 394.42 425.565 434.632
    现金等价物 140.745 161.9 186.409 218.72 269.303
    短期投资 209.642 217.271 208.011 206.845 165.329
    Prepaid Expenses 5.042 4.608 3.158 3.205 3.366
    Total Assets 531.847 558.45 576.379 601.324 616.874
    Property/Plant/Equipment, Total - Net 170.887 169.726 166.039 159.493 145.38
    Property/Plant/Equipment, Total - Gross 178.773 176.519 171.84 164.644 150.056
    Accumulated Depreciation, Total -7.886 -6.793 -5.801 -5.151 -4.676
    Other Long Term Assets, Total 0.402 0.324 0.205 0.159 0.157
    Total Current Liabilities 35.076 28.847 28.032 34.427 60.437
    Accounts Payable 4.109 3.981 5.761 9.229 8.209
    Accrued Expenses 30.595 24.556 21.681 24.879 51.937
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.372 0.31 0.59 0.319 0.291
    Total Liabilities 42.281 36.219 35.607 42.143 68.32
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 7.205 7.372 7.575 7.716 7.883
    Total Equity 489.566 522.231 540.772 559.181 548.554
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.00026 0.00026 0.00026 0.00026 0.00025
    Additional Paid-In Capital 815.776 803.718 790.954 779.583 740.5
    Retained Earnings (Accumulated Deficit) -326.056 -280.759 -248.707 -218.857 -190.749
    Other Equity, Total -0.15426 -0.72826 -1.47526 -1.54526 -1.19725
    Total Liabilities & Shareholders’ Equity 531.847 558.45 576.379 601.324 616.874
    Total Common Shares Outstanding 25.7962 25.7637 25.7097 25.6643 25.1991
    Long Term Investments 5.129 4.621 12.557 12.902 33.339
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -139.975 -69.57 -32.167 -19.088 -10.889
    经营活动产生的现金 -100.569 -47.938 -26.083 -18.69 -9.445
    经营活动产生的现金 4.055 2.769 1.851 1.09 0.141
    非现金物品 32.54 16.811 3.305 1.306 0.792
    Cash Taxes Paid
    已付现金利息
    营运资金的变化 2.811 2.052 0.928 -1.998 0.511
    投资活动产生的现金 -114.083 -226.77 -11.181 -4.991 -10.323
    资本支出 -52.979 -68.336 -14.843 -6.399 -2.234
    融资活动产生的现金 35.347 347.685 118.019 107.525 73.847
    股票的发行（报废），净额 35.996 355.645 118.019 107.525 73.847
    债务的发行（退还），净额 0
    现金净变化 -179.346 72.977 80.755 83.844 54.079
    其他投资现金流量项目，总计 -61.104 -158.434 3.662 1.408 -8.089
    融资现金流项目 -0.649 -7.96
    外汇效应 -0.041
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -45.297 -139.975 -107.923 -78.073 -49.965
    Cash From Operating Activities -26.156 -100.569 -78.24 -58.552 -15.493
    Cash From Operating Activities 0.705 4.055 2.966 1.991 1.015
    Non-Cash Items 9.832 32.54 23.476 14.453 6.295
    Changes in Working Capital 8.604 2.811 3.241 3.077 27.162
    Cash From Investing Activities 3.563 -114.083 -108.875 -94.132 -55.908
    Capital Expenditures -5.381 -52.979 -47.762 -33.706 -17.191
    Other Investing Cash Flow Items, Total 8.944 -61.104 -61.113 -60.426 -38.717
    Cash From Financing Activities 1.474 35.347 32.278 30.158 -0.542
    Financing Cash Flow Items -0.749 -0.649 -0.649 -0.649 -0.649
    Issuance (Retirement) of Stock, Net 2.223 35.996 32.927 30.807 0.107
    Net Change in Cash -21.155 -179.346 -154.837 -122.526 -71.943
    Foreign Exchange Effects -0.036 -0.041
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Fidelity Management & Research Company LLC Investment Advisor 9.4926 2613272 512196 2023-04-28 LOW
    Redmile Group, LLC Investment Advisor/Hedge Fund 6.9499 1913280 16635 2023-03-31 LOW
    Krishnan (Krish S) Individual Investor 6.3907 1759338 -115000 2023-04-17 LOW
    Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 6.3568 1750000 340000 2023-03-31
    Krishnan (Suma M) Individual Investor 6.3176 1739206 -75000 2023-04-17 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.2716 1451254 10968 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.3551 1198944 14120 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.7284 1026395 -12588 2023-03-31 LOW
    Lord, Abbett & Co. LLC Investment Advisor 3.4917 961242 -316780 2023-03-31 MED
    Frazier Healthcare Partners Venture Capital 3.4342 945407 -54330 2023-03-31 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.2987 632819 -50060 2023-03-31 LOW
    Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 2.2971 632393 6414 2023-03-31 LOW
    Point72 Asset Management, L.P. Hedge Fund 1.825 502400 -53852 2023-03-31 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.6785 462090 72805 2023-03-31 LOW
    Hood River Capital Management LLC Investment Advisor 1.6251 447393 20514 2023-03-31 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.564 430571 18444 2023-03-31 LOW
    Invus Public Equities Advisors, LLC Investment Advisor 1.4969 412082 12082 2023-03-31 LOW
    Nicholas Investment Partners, L.P. Investment Advisor/Hedge Fund 1.3612 374718 107629 2023-03-31 HIGH
    Braidwell LP Hedge Fund 1.2642 348036 -10020 2023-03-31
    Deerfield Management Company, L.P. Hedge Fund 1.1331 311949 136949 2023-03-31 MED

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    530K+

    交易者

    87K+

    每月活跃客户

    $46M+

    每月投资额

    $31M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Krystal Biotech, Inc. Company profile

    关于 Krystal Biotech Inc.

    Krystal Biotech, Inc.是一家处于临床阶段的生物技术公司，专注于治疗严重罕见疾病的可重用基因传递。 公司利用其基于工程化单纯疱疹病毒1型（HSV-1）的平台，创建了向多个器官系统中的相关细胞传递治疗性转基因的载体。 公司的基因治疗候选产品正在进行B-VEC、KB105、KB301、KB104、KB407和KB408的临床前研究和临床试验。 公司的KB104是为了治疗Netherton综合症，这是一种严重的鱼鳞病，是一种遗传性皮肤病，与增厚的鳞状皮肤有关，以慢性皮肤炎症、瘙痒和脱水为特征。

    Industry: Bio Therapeutic Drugs

    2100 Wharton St Ste 701
    PITTSBURGH
    PENNSYLVANIA 15203
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    US100

    14,346.30 Price
    +0.140% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    Oil - Crude

    72.83 Price
    -0.150% 1D Chg, %
    多头隔夜费 -0.0146%
    空头隔夜费 -0.0073%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    XRP/USD

    0.50 Price
    +3.370% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00414

    BTC/USD

    27,667.30 Price
    +0.310% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    还在找一位您可以信任的经纪商吗？

    加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易